pubmed-article:18160525 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18160525 | lifeskim:mentions | umls-concept:C0085112 | lld:lifeskim |
pubmed-article:18160525 | lifeskim:mentions | umls-concept:C0026336 | lld:lifeskim |
pubmed-article:18160525 | lifeskim:mentions | umls-concept:C0007585 | lld:lifeskim |
pubmed-article:18160525 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
pubmed-article:18160525 | lifeskim:mentions | umls-concept:C0085319 | lld:lifeskim |
pubmed-article:18160525 | lifeskim:mentions | umls-concept:C0526702 | lld:lifeskim |
pubmed-article:18160525 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:18160525 | pubmed:dateCreated | 2008-2-26 | lld:pubmed |
pubmed-article:18160525 | pubmed:abstractText | The anticryptosporidial activity of Bobel-24 (2,4,6-triiodophenol) was studied for the first time, resulting in a reduction of the in vitro growth of Cryptosporidium of up to 99.6%. In a SCID mouse model of chronic cryptosporidiosis, significant differences (P < 0.05) in oocyst shedding were observed in animals treated with 125 mg/kg/day. These results merit further investigation of Bobel-24 as a chemotherapeutic option for cryptosporidiosis. | lld:pubmed |
pubmed-article:18160525 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18160525 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18160525 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18160525 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18160525 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18160525 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18160525 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18160525 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18160525 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18160525 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18160525 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18160525 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18160525 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18160525 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18160525 | pubmed:language | eng | lld:pubmed |
pubmed-article:18160525 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18160525 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18160525 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18160525 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18160525 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18160525 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18160525 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18160525 | pubmed:month | Mar | lld:pubmed |
pubmed-article:18160525 | pubmed:issn | 0066-4804 | lld:pubmed |
pubmed-article:18160525 | pubmed:author | pubmed-author:FenoySoledadS | lld:pubmed |
pubmed-article:18160525 | pubmed:author | pubmed-author:Del... | lld:pubmed |
pubmed-article:18160525 | pubmed:author | pubmed-author:RuedaCristina... | lld:pubmed |
pubmed-article:18160525 | pubmed:author | pubmed-author:SimónFernando... | lld:pubmed |
pubmed-article:18160525 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:18160525 | pubmed:volume | 52 | lld:pubmed |
pubmed-article:18160525 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18160525 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18160525 | pubmed:pagination | 1150-2 | lld:pubmed |
pubmed-article:18160525 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
pubmed-article:18160525 | pubmed:meshHeading | pubmed-meshheading:18160525... | lld:pubmed |
pubmed-article:18160525 | pubmed:meshHeading | pubmed-meshheading:18160525... | lld:pubmed |
pubmed-article:18160525 | pubmed:meshHeading | pubmed-meshheading:18160525... | lld:pubmed |
pubmed-article:18160525 | pubmed:meshHeading | pubmed-meshheading:18160525... | lld:pubmed |
pubmed-article:18160525 | pubmed:meshHeading | pubmed-meshheading:18160525... | lld:pubmed |
pubmed-article:18160525 | pubmed:meshHeading | pubmed-meshheading:18160525... | lld:pubmed |
pubmed-article:18160525 | pubmed:meshHeading | pubmed-meshheading:18160525... | lld:pubmed |
pubmed-article:18160525 | pubmed:meshHeading | pubmed-meshheading:18160525... | lld:pubmed |
pubmed-article:18160525 | pubmed:meshHeading | pubmed-meshheading:18160525... | lld:pubmed |
pubmed-article:18160525 | pubmed:meshHeading | pubmed-meshheading:18160525... | lld:pubmed |
pubmed-article:18160525 | pubmed:meshHeading | pubmed-meshheading:18160525... | lld:pubmed |
pubmed-article:18160525 | pubmed:meshHeading | pubmed-meshheading:18160525... | lld:pubmed |
pubmed-article:18160525 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18160525 | pubmed:articleTitle | Bobel-24 activity against Cryptosporidium parvum in cell culture and in a SCID mouse model. | lld:pubmed |
pubmed-article:18160525 | pubmed:affiliation | Sección de Parasitología, Departamento de Bioquímica, Biología Celular y Molecular, Facultad de Farmacia, Universidad San Pablo CEU, Urbanización Montepríncipe, Ctra. Boadilla del Monte km 5,300, 28668 Madrid, Spain. | lld:pubmed |
pubmed-article:18160525 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:18160525 | lld:chembl |